This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
The New England journal of medicine, 389(6), 514-526
Citation
Jastreboff, Ania M; Kaplan, Lee M; Frías, Juan P; Wu, Qiwei; Du, Yu; Gurbuz, Sirel; Coskun, Tamer; Haupt, Axel; Milicevic, Zvonko; Hartman, Mark L. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.. The New England journal of medicine, 389(6), 514-526. https://doi.org/10.1056/NEJMoa2301972